Keler Tibor's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Dec 9, 2022
- Accession no.
- 0001415889-22-012301
- Filed
- Dec 9, 2022
- Trade date
- Dec 7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $622.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Keler TiborCIK 0001429931 | Officer (EXECUTIVE VP & CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2022 | Common Stock, par value $0.001 per share | MOption exerciseAcquired | +16,860 | $2.78 | +$46,870.8 | 24,217 | Direct | |
| Dec 7, 2022 | Common Stock, par value $0.001 per share | SSaleDisposed | −16,860 | $36.93 | −$622,639.8 | 7,357 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2022 | Common Stock | MOption exerciseDisposed | −16,860 | $0.00 | $0 | 43,140 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.